生物标志物 生物标志物
Simone P Zehntner1, Jean-Philippe Coutu1, Felix Carbonell1
1Biospective Inc., Montreal, QC, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
先进的MRI技术揭示了前性痴呆症 (FTD) 亚型中明显的脑缩模式,使得FTD治疗的临床试验更小,更有效.
科学领域:
- 神经成像是一种神经成像.
- 神经退行性疾病 神经退行性疾病
- 生物标志物发现发现
背景情况:
- 前性痴呆症 (FTD) 是一组影响前和叶的神经退行性疾病.
- 关键的亚型包括行为变体FTD (bvFTD),语义变体初级渐进性失语症 (svPPA) 和非流利变体初级渐进性失语症 (nfvPPA).
- 准确的诊断和进展监测对于开发有效疗法至关重要.
研究的目的:
- 识别敏感的成像生物标志物,以区分FTD亚型.
- 通过估计所需样本大小,优化临床试验设计.
- 为了提高可靠性,利用先进的自动化处理.
主要方法:
- 使用PIANOTM自动化管道对238名参与者进行体积和扩散MRI (dMRI) 分析 (52名bvFTD,32名nfvPPA,35名svPPA,117名对照).
- 评估灰色物质密度,平均扩散率 (MD) 和自由水 (FW).
- 执行了样本大小计算,以检测在6-24个月内指标减少了60%,并结合了深度学习细分.
主要成果:
- 观察到明显的缩模式:svPPA在海马体和皮层表现出快速进展 (24个月内体积损失高达15%).
- bvFTD表现出额头和带肌的变化; nfvPPA显示出较少的局部变化.
- 对svPPA的样本大小需求最低 (在6-12个月的试验中,每组<35名参与者),PIANOTM分析显示灵敏度更高,需求减少.
结论:
- 先进的成像生物标志物有效地区分FTD亚型并监测进展.
- 体积学,dMRI和深度学习的整合增强了早期检测,并减少了临床试验样本大小.
- 这种方法促进了成本效益高的试验和基于亚型特定进展模式的个性化干预策略.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516